Antidepressant Medication Use and Non-Hodgkin’s Lymphoma Risk: No Association
Identifieur interne : 001845 ( Istex/Checkpoint ); précédent : 001844; suivant : 001846Antidepressant Medication Use and Non-Hodgkin’s Lymphoma Risk: No Association
Auteurs : Saira Bahl [Canada] ; Michelle Cotterchio [Canada] ; Nancy Kreiger [Canada] ; Neil Klar [Canada]Source :
- American Journal of Epidemiology [ 0002-9262 ] ; 2004-09-15.
English descriptors
- KwdEn :
- Teeft :
- Alcohol consumption, Antidepressant, Antidepressant medication, Antidepressant medications, Asor, Cancer care ontario, Cancer incidence, Cancer risk, Cancer surveillance study, Clinical depression, Confidence interval, Diagnosis date, Dietary factors, Epidemiol, Epidemiol antidepressant medication, Fluoxetine, Frequency distribution, Inhibitor, Lymphoma, Lymphoma risk, Medication, Natl cancer inst, Odds ratio, Odds ratio estimates, Odds ratios, Older women, Ontario, Ontario cancer registry, Public health, Quartile, Renal transplantation, Reuptake, Selective serotonin reuptake inhibitors, Serotonin, Specific types, Ssri, Standardized incidence ratio, Tertile, Total number, Tricyclic, Tricyclic antidepressant medication, Tricyclic antidepressants, Wood dust.
Abstract
Animal and human studies have suggested that antidepressant medications may be associated with several cancers. The authors evaluated the association between antidepressant medication use and the risk of non-Hodgkin’s lymphoma using a Canadian population-based case-control study, the National Enhanced Cancer Surveillance Study. Non-Hodgkin’s lymphoma cases (n = 638) diagnosed in 1995–1996 were identified using the Ontario Cancer Registry, and controls (n = 1,930) were identified from the Ontario Ministry of Finance Property Assessment Database. Antidepressant medication use was ascertained using a self-administered questionnaire. Multivariate logistic regression was used to estimate odds ratios. “Ever” use of antidepressant medications was not associated with non-Hodgkin’s lymphoma risk. The odds ratio for non-Hodgkin’s lymphoma with 25 or more months of tricyclic antidepressant medication use was 1.6; however, this was nonsignificant. Duration or history of use or individual types of antidepressant medications were not associated with non-Hodgkin’s lymphoma risk. These findings do not support an increased risk of non-Hodgkin’s lymphoma with antidepressant medication use.
Url:
DOI: 10.1093/aje/kwh234
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:63EC04422450EFD341801D54D36D5D0B3C34E0A1Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antidepressant Medication Use and Non-Hodgkin’s Lymphoma Risk: No Association</title><author><name sortKey="Bahl, Saira" sort="Bahl, Saira" uniqKey="Bahl S" first="Saira" last="Bahl">Saira Bahl</name></author><author><name sortKey="Cotterchio, Michelle" sort="Cotterchio, Michelle" uniqKey="Cotterchio M" first="Michelle" last="Cotterchio">Michelle Cotterchio</name></author><author><name sortKey="Kreiger, Nancy" sort="Kreiger, Nancy" uniqKey="Kreiger N" first="Nancy" last="Kreiger">Nancy Kreiger</name></author><author><name sortKey="Klar, Neil" sort="Klar, Neil" uniqKey="Klar N" first="Neil" last="Klar">Neil Klar</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:63EC04422450EFD341801D54D36D5D0B3C34E0A1</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1093/aje/kwh234</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-1KMBQZSZ-G/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001728</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001728</idno><idno type="wicri:Area/Istex/Curation">001709</idno><idno type="wicri:Area/Istex/Checkpoint">001845</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001845</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Antidepressant Medication Use and Non-Hodgkin’s Lymphoma Risk: No Association</title><author><name sortKey="Bahl, Saira" sort="Bahl, Saira" uniqKey="Bahl S" first="Saira" last="Bahl">Saira Bahl</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Preventive Oncology, Cancer Care Ontario, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Cotterchio, Michelle" sort="Cotterchio, Michelle" uniqKey="Cotterchio M" first="Michelle" last="Cotterchio">Michelle Cotterchio</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Preventive Oncology, Cancer Care Ontario, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Public Health Sciences, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Kreiger, Nancy" sort="Kreiger, Nancy" uniqKey="Kreiger N" first="Nancy" last="Kreiger">Nancy Kreiger</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Preventive Oncology, Cancer Care Ontario, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Public Health Sciences, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Nutritional Sciences, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Klar, Neil" sort="Klar, Neil" uniqKey="Klar N" first="Neil" last="Klar">Neil Klar</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Preventive Oncology, Cancer Care Ontario, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Public Health Sciences, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">American Journal of Epidemiology</title><title level="j" type="abbrev">Am. J. Epidemiol.</title><idno type="ISSN">0002-9262</idno><idno type="eISSN">1476-6256</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2004-09-15">2004-09-15</date><biblScope unit="volume">160</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="566">566</biblScope><biblScope unit="page" to="575">575</biblScope></imprint><idno type="ISSN">0002-9262</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-9262</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abbreviations: ASOR, age- and sex-adjusted odds ratio; CI, confidence interval; SSRI, selective serotonin reuptake inhibitor.</term><term>antidepressive agents; case-control studies; lymphoma, non-Hodgkin; neoplasms</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Alcohol consumption</term><term>Antidepressant</term><term>Antidepressant medication</term><term>Antidepressant medications</term><term>Asor</term><term>Cancer care ontario</term><term>Cancer incidence</term><term>Cancer risk</term><term>Cancer surveillance study</term><term>Clinical depression</term><term>Confidence interval</term><term>Diagnosis date</term><term>Dietary factors</term><term>Epidemiol</term><term>Epidemiol antidepressant medication</term><term>Fluoxetine</term><term>Frequency distribution</term><term>Inhibitor</term><term>Lymphoma</term><term>Lymphoma risk</term><term>Medication</term><term>Natl cancer inst</term><term>Odds ratio</term><term>Odds ratio estimates</term><term>Odds ratios</term><term>Older women</term><term>Ontario</term><term>Ontario cancer registry</term><term>Public health</term><term>Quartile</term><term>Renal transplantation</term><term>Reuptake</term><term>Selective serotonin reuptake inhibitors</term><term>Serotonin</term><term>Specific types</term><term>Ssri</term><term>Standardized incidence ratio</term><term>Tertile</term><term>Total number</term><term>Tricyclic</term><term>Tricyclic antidepressant medication</term><term>Tricyclic antidepressants</term><term>Wood dust</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Animal and human studies have suggested that antidepressant medications may be associated with several cancers. The authors evaluated the association between antidepressant medication use and the risk of non-Hodgkin’s lymphoma using a Canadian population-based case-control study, the National Enhanced Cancer Surveillance Study. Non-Hodgkin’s lymphoma cases (n = 638) diagnosed in 1995–1996 were identified using the Ontario Cancer Registry, and controls (n = 1,930) were identified from the Ontario Ministry of Finance Property Assessment Database. Antidepressant medication use was ascertained using a self-administered questionnaire. Multivariate logistic regression was used to estimate odds ratios. “Ever” use of antidepressant medications was not associated with non-Hodgkin’s lymphoma risk. The odds ratio for non-Hodgkin’s lymphoma with 25 or more months of tricyclic antidepressant medication use was 1.6; however, this was nonsignificant. Duration or history of use or individual types of antidepressant medications were not associated with non-Hodgkin’s lymphoma risk. These findings do not support an increased risk of non-Hodgkin’s lymphoma with antidepressant medication use.</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Canada"><noRegion><name sortKey="Bahl, Saira" sort="Bahl, Saira" uniqKey="Bahl S" first="Saira" last="Bahl">Saira Bahl</name></noRegion><name sortKey="Cotterchio, Michelle" sort="Cotterchio, Michelle" uniqKey="Cotterchio M" first="Michelle" last="Cotterchio">Michelle Cotterchio</name><name sortKey="Cotterchio, Michelle" sort="Cotterchio, Michelle" uniqKey="Cotterchio M" first="Michelle" last="Cotterchio">Michelle Cotterchio</name><name sortKey="Klar, Neil" sort="Klar, Neil" uniqKey="Klar N" first="Neil" last="Klar">Neil Klar</name><name sortKey="Klar, Neil" sort="Klar, Neil" uniqKey="Klar N" first="Neil" last="Klar">Neil Klar</name><name sortKey="Kreiger, Nancy" sort="Kreiger, Nancy" uniqKey="Kreiger N" first="Nancy" last="Kreiger">Nancy Kreiger</name><name sortKey="Kreiger, Nancy" sort="Kreiger, Nancy" uniqKey="Kreiger N" first="Nancy" last="Kreiger">Nancy Kreiger</name><name sortKey="Kreiger, Nancy" sort="Kreiger, Nancy" uniqKey="Kreiger N" first="Nancy" last="Kreiger">Nancy Kreiger</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001845 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 001845 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Lorraine
|area= InforLorV4
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:63EC04422450EFD341801D54D36D5D0B3C34E0A1
|texte= Antidepressant Medication Use and Non-Hodgkin’s Lymphoma Risk: No Association
}}
| This area was generated with Dilib version V0.6.33. |  |